Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects*
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Most of the literature on phase one trials has focused on ethical and safety issues in research on patients with advanced cancer, but this article focuses on healthy, adult subjects. The article makes six specific recommendations for protecting the rights and welfare of healthy subjects in phase one trials: 1) because phase one trials are short in duration (usually 1 to 3 months), researchers should gather more data on the short-term and long-term risks of participation in phase one studies by healthy subjects; 2) researchers should develop strict inclusion/exclusion criteria that exclude unhealthy or vulnerable subjects, such as decisionally impaired people, in phase one studies; 3) subjects should not participate in more than one phase one study at the same time and should wait at least 30 days between participating in different studies; 4) researchers should develop a database to keep track of phase one participants; 5) subjects should be guaranteed a minimum wage equivalent to the equivalent type of unskilled labor, but there should be no upper limits on wages; and 6) subjects should be allowed to engage in collective bargaining with research sponsors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
The influence of risk and monetary payment on the research participation decision making process
Bentley, J. P., & Thacker, P. G. (2004) · Journal of Medical Ethics · doi:10.1136/jme.2002.001594 · Cited by 316 · cited 1×
“A recent study by Bentley and Thacker (2004) shows that money can influence the decision to participate in research but that it does not blind subjects to high risks.”
BackgroundResponsible Conduct of Research
Shamoo, A. E., & Resnik, D. B. (2022) · doi:10.1093/oso/9780197547090.001.0001 · Cited by 224
Self-citation
Cited by
Responsible Conduct of Research
Shamoo, A. E., & Resnik, D. B. (2022) · doi:10.1093/oso/9780197547090.001.0001 · Cited by 224
Self-citationDahabreh, I. J. (2011) · JAMA · doi:10.1001/jama.2011.336 · Cited by 199
The clinical investigator-subject relationship: a contextual approach
Resnik, D. B. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-16 · Cited by 32
“Subjects are usually paid a considerable sum of money for their participation [83].”
Self-citationEthical flaws in the TeGenero trial
Shamoo, A., & Woeckner, E. (2007) · The American Journal of Bioethics · doi:10.1080/15265160601112204 · Cited by 20
“Regulatory compliance is a necessary but insufficient condition for ethical research ( Shamoo and Resnik 2006 ).”
BackgroundSelf-citation
Metadata
- Authors
- Shamoo, A. E., & Resnik, D. B.
- Venue
- The American Journal of Bioethics
- Publisher
- Informa UK Limited
- Published
- 2006-07
- Volume
- 6
- Issue
- 3
- Pages
- W1-W13
- ISSN
- 1526-5161 (ISSN-L)
- 1536-0075
- OpenAlex
- W2064849044
- Cited by
- 74
- References
- 3
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects*. https://app.cochat.ai/papers/10.1080/15265160600686281
- The paper
- Shamoo, A. E., & Resnik, D. B. (2006). Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects*. The American Journal of Bioethics. https://doi.org/10.1080/15265160600686281
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.